Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

CHITOSAN NANOPARTICLES IN PULMONARY DRUG DELIVERY HELPFUL FOR COVID-19 TREATMENT: A REVIEW

  Authors

  Mitesh M Bhosle,  Harshada P Chavan,  Dr Pradnya K Ingle,  Girish Deshmukh

  Keywords

chitosan, nanoparticle, pulmonary drug delivery, covid-19

  Abstract


Objective- Chitosan is derived from chitin through deacetylation process. Production of Chitosan takes place in 4 steps. Chitosan is natural cationic polysaccharide which is rich in source. Chitosan has unique physiochemical properties, good biocompatibility and satisfactory biodegradability. Chitosan contain amino group. Chitosan has been popular biomaterial in pharmaceutics from decades and widely used in drug delivery. Chitin is extracted by removing protein and calcium carbonate from the raw shell. Purpose- Chitosan is soluble in acidic solution but precipitate obtained i.e. solids has very high PH values. By treating Chitosan with various PH, changes in their physical forms can be seen. Basically Chitosan is non-toxic to humans, plants, animals and because of its lack in toxicity where lot of application can be observed in environmental, agricultural, food, pharmaceutical industry. The importance of Chitosan can be also seen in drug delivery in humans to solve various diseases. Results- Due to its sub-micron size it is suitable for mucosal routes i.e. oral, nasal and ocular nanoparticle showed to be a good adjuvant for vaccine development. Chitosan is also used is polymeric nanoparticle through various route. Chitosan is added in aqueous acidic solution and then the aqueous solution of TPP is added under vigorous stirring. In this Anionic molecules diffuse in positively charged chitosan molecule and then crosslinking occurs leading to nanoparticle formation. Various production method for drug delivery take place. Using multiple method, application can also be seen in Covid-19 drug delivery.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2107229

  Paper ID - 209957

  Page Number(s) - b850-b858

  Pubished in - Volume 9 | Issue 7 | July 2021

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Mitesh M Bhosle,  Harshada P Chavan,  Dr Pradnya K Ingle,  Girish Deshmukh,   "CHITOSAN NANOPARTICLES IN PULMONARY DRUG DELIVERY HELPFUL FOR COVID-19 TREATMENT: A REVIEW", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.9, Issue 7, pp.b850-b858, July 2021, Available at :http://www.ijcrt.org/papers/IJCRT2107229.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper July 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer